𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI

✍ Scribed by D. Pouliquen; H. Perroud; F. Calza; P. Jallet; J. J. Le Jeune

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
756 KB
Volume
24
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Superparamagnetic iron oxide particles, a new class of contrast agents for MRI, are extremely good enhancers of proton relaxation. However, the development of such particle systems has resulted in a wide range of preparations whose physico‐chemical properties differ greatly. We have conducted a set of physical experiments: X ray diffraction analysis, relaxivity measurements, susceptibility determinations, and thermomagnetic cycling on different preparations of superparamagnetic particles. Our results demonstrate a good correlation between susceptibilities measured in liquid samples at room temperature and the R2/RI ratio. Susceptibility measurements between liquid nitrogen temperature and room temperature show three different types of behavior dependent on the size of iron oxide crystals. Comparison of heating and cooling curves from strong field thermomagnetic cycles provides information about the maghemite/magnetite crystal content. The information on magnetic properties reported in this study may help to characterize and to select these materials for use as MRI contrast agents. © 1992 Academic Press, Inc.

📜 SIMILAR VOLUMES

Synthesis of Iron Oxide Nanoparticles Us
Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study
✍ Lucia Babes; Benoı̂t Denizot; Gisèle Tanguy; Jean Jacques Le Jeune; P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Colloidal iron oxides play an important role as magnetic resonance imaging (MRI) contrast agents. The superparamagnetic particles actually used are constituted by solid cores (diameter of 5-15 nm), generally coated by a thick polysaccharidic layer (hydrodynamic radii of 30-100 nm), and formulated by

Nonpolymeric Coatings of Iron Oxide Coll
Nonpolymeric Coatings of Iron Oxide Colloids for Biological Use as Magnetic Resonance Imaging Contrast Agents
✍ David Portet; Benoı̂t Denizot; Elmar Rump; Jean-Jacques Lejeune; Pier 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Iron oxide nanoparticles are used in vivo as contrast agents in magnetic resonance imaging. Their widely used polymer coatings are directly involved in their biocompatibility and avoid magnetic aggregation. As these polymer brushes also limit their tissular diffusion due to important hydrodynamic si

Renal T perfusion using an iron oxide na
Renal T perfusion using an iron oxide nanoparticle contrast agent—influence of T1 relaxation on the first-pass response
✍ Atle Bjørnerud; Lars O. Johansson; Håkan K. Ahlström 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract Quantitative perfusion measurements require accurate knowledge of the correlation between first‐pass signal changes and the corresponding tracer concentration in tissue. In the present study, a detailed analysis of first‐pass renal cortical changes in __T__~1~ and __T__ following bolus

Iron–dextran as a magnetic susceptibilit
Iron–dextran as a magnetic susceptibility contrast agent: Flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain
✍ David L. White; Klaus P. Aicher; A. Aria Tzika; John Kucharczyk; Barry L. Engels 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

## Abstract Iron–dextran (1 mmol Fe/kg) was used as an intravascular, paramagnetic contrast agent in rat and cat brain in conventional spin‐echo T2‐weighted (TR 2800/TE 100) ^1^H magnetic resonance imaging. The resulting images displayed differential decreases (30–50%) in intensity whose pattern wa

Biliary excretion and pharmacokinetics o
Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat
✍ Gabriele Schuhmann-Giampieri; Heribert Schitt-Willich; Thomas Frenzel 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

The introduction of a lipophilic moiety into the gadolinium chelate Gd-DTPA (dimeglumine gadopentetate, Magnevist) yielded Gd-EOB-DTPA (short form), which has potential as a magnetic resonance contrast agent for liver mass screening. The pharmacokinetics of Gd-EOB-DTPA in rats is nonlinear because a

Comparison of dysprosium DTPA BMA and su
Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat
✍ Olav Haraldseth; Richard A. Jones; Tomm B. Müller; Anne K. Fahlvik; Audun N. Øks 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

## Abstract The aim of the study was to compare the first‐passage profiles of dysprosium diethylenetriamine penta‐acetic acid bis(methylamide) (DTPA BMA) and the superparamagnetic iron oxide particles NSR 0430 in regions with severe and moderate cerebral ischemia. In seven rats subjected to middle